Featured Image for NC Physicians For Freedom
North Carolina Physicians' Group Calls for Halt to Atrium COVID Vaccine Trial for Children
19. Mai 2022 20:00 ET | NC Physicians For Freedom
WINSTON-SALEM, N.C., May 19, 2022 (GLOBE NEWSWIRE) -- The North Carolina Physicians for Freedom (NCPFF), a large network of physicians and other health care professionals, called for the cessation...
PastedGraphic-7.png
First Patient Dosed in AstraZeneca’s Phase III COVID-19 Vaccine Trial at Headlands’ JEM Research Institute Site in Florida
01. September 2020 09:00 ET | Headlands Research
SAN FRANCISCO, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Headlands Research is pleased to announce that on Friday, Aug. 28, its JEM Research Institute clinical trial site in Lake Worth, Florida,...
PastedGraphic-7.png
Multiple Headlands Research Sites Selected for AstraZeneca’s Phase III COVID-19 Vaccine Trial
11. August 2020 09:00 ET | Headlands Research
SAN FRANCISCO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Headlands Research announced today that its research centers have been selected to participate in AstraZeneca’s upcoming Phase III COVID-19 vaccine...
PastedGraphic-7.png
Headlands Research Sites Chosen for Crucial COVID-19 Vaccine Trials
16. Juli 2020 13:28 ET | Headlands Research
SAN FRANCISCO, July 16, 2020 (GLOBE NEWSWIRE) -- Headlands Research announced today that its research centers have been selected to participate in numerous upcoming COVID-19 vaccine clinical trials....
Syneos Health_rgb_r.jpg
INC Research Bolsters Support for Vaccine Trials through Expanded Site and Patient Initiatives
06. April 2017 14:52 ET | INC Research, LLC
RALEIGH, N.C., April 06, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to IV contract research organization, will demonstrate its continued commitment...
Syneos Health_rgb_r.jpg
INC Research Extends Catalyst Program with Launch of Vaccine Catalyst Site Network
27. Juli 2016 09:52 ET | INC Research, LLC
RALEIGH, N.C., July 27, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced the launch of the...